Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Incidence of Cushing Syndrome, Acromegaly and Other Associated Diseases
5.1.1.2. Extensive Spending on Development of Drugs for Rare Diseases Globally
5.1.1.3. Favorable Government Policies and Schemes for Patients with Rare Diseases
5.1.2. Restraints
5.1.2.1. Reduced Awareness Resulting in a High Number of Undiagnosed Patients
5.1.3. Opportunities
5.1.3.1. Ongoing Research and Development Activities for the Launch of Novel Drug Therapeutics
5.1.3.2. Strategic Collaboration Among Pharmaceutical and Research Companies
5.1.4. Challenges
5.1.4.1. Availability of Alternative Treatment Methods for Diseases Such as Acromegaly
5.2. Market Segmentation Analysis
5.2.1. Type: Growing preference for octreotide due to its safety and efficacy
5.2.2. Application: Utilization of somatostatin analogs for the treatment of acromegaly due to their greater potency and longer half life
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis

6. Somatostatin Analogs Market, by Type
6.1. Introduction
6.2. Lanreotide
6.3. Octreotide
6.4. Pasireotide

7. Somatostatin Analogs Market, by Application
7.1. Introduction
7.2. Acromegaly
7.3. Neuroendocrine Tumors

8. Americas Somatostatin Analogs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Somatostatin Analogs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Somatostatin Analogs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. FDA selects RayzeBio to Participate in the Inaugural CDRP Program to Expedite Commercial Manufacturing Readiness for RYZ101 in GEP-NETs
11.3.2. Ipsen announces investment in new electronic autoinjector for Somatuline Autogel / Somatuline Depot (lanreotide) designed to improve patient experience
11.3.3. European Commission approves Mycapssa for the treatment of Acromegaly

12. Competitive Portfolio
12.1. Key Company Profiles
12.2. Key Product Portfolio



List of Figures

FIGURE 1. SOMATOSTATIN ANALOGS MARKET RESEARCH PROCESS
FIGURE 2. SOMATOSTATIN ANALOGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SOMATOSTATIN ANALOGS MARKET DYNAMICS
FIGURE 7. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. SOMATOSTATIN ANALOGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 20. SOMATOSTATIN ANALOGS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. SOMATOSTATIN ANALOGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY LANREOTIDE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY LANREOTIDE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY OCTREOTIDE, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY OCTREOTIDE, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY PASIREOTIDE, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY PASIREOTIDE, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY ACROMEGALY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY ACROMEGALY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL SOMATOSTATIN ANALOGS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 22. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 23. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 24. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 25. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 26. AMERICAS SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 27. ARGENTINA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 28. ARGENTINA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 29. ARGENTINA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. ARGENTINA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. BRAZIL SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 32. BRAZIL SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 33. BRAZIL SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 34. BRAZIL SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 35. CANADA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 36. CANADA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 37. CANADA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. CANADA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. MEXICO SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 40. MEXICO SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 41. MEXICO SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. MEXICO SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 44. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 45. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 46. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 47. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 48. UNITED STATES SOMATOSTATIN ANALOGS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 50. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 52. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 54. ASIA-PACIFIC SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 55. AUSTRALIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 56. AUSTRALIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 57. AUSTRALIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. AUSTRALIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. CHINA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 60. CHINA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 61. CHINA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. CHINA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. INDIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. INDIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. INDIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. INDIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. INDONESIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 68. INDONESIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 69. INDONESIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. INDONESIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. JAPAN SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 72. JAPAN SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 73. JAPAN SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. JAPAN SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. MALAYSIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 76. MALAYSIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 77. MALAYSIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. MALAYSIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. PHILIPPINES SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 80. PHILIPPINES SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 81. PHILIPPINES SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. PHILIPPINES SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. SINGAPORE SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 84. SINGAPORE SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 85. SINGAPORE SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. SINGAPORE SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. SOUTH KOREA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 88. SOUTH KOREA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 89. SOUTH KOREA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. SOUTH KOREA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. TAIWAN SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. TAIWAN SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. TAIWAN SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. TAIWAN SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. THAILAND SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 96. THAILAND SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 97. THAILAND SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. THAILAND SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. VIETNAM SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 100. VIETNAM SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 101. VIETNAM SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. VIETNAM SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 109. DENMARK SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. DENMARK SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. DENMARK SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. DENMARK SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. EGYPT SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 114. EGYPT SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 115. EGYPT SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. EGYPT SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. FINLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 118. FINLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 119. FINLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. FINLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. FRANCE SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. FRANCE SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. FRANCE SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. FRANCE SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. GERMANY SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. GERMANY SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. GERMANY SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. GERMANY SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. ISRAEL SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 130. ISRAEL SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 131. ISRAEL SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. ISRAEL SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. ITALY SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. ITALY SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. ITALY SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. ITALY SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. NETHERLANDS SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 138. NETHERLANDS SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 139. NETHERLANDS SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. NETHERLANDS SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. NIGERIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 142. NIGERIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 143. NIGERIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. NIGERIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. NORWAY SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. NORWAY SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. NORWAY SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. NORWAY SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. POLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. POLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. POLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. POLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. QATAR SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 154. QATAR SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 155. QATAR SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. QATAR SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. RUSSIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. RUSSIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. RUSSIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. RUSSIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 162. SAUDI ARABIA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. SAUDI ARABIA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. SOUTH AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. SOUTH AFRICA SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. SPAIN SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 170. SPAIN SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 171. SPAIN SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. SPAIN SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. SWEDEN SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 174. SWEDEN SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 175. SWEDEN SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. SWEDEN SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. SWITZERLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. SWITZERLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. SWITZERLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. SWITZERLAND SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. TURKEY SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. TURKEY SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. TURKEY SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. TURKEY SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. UNITED KINGDOM SOMATOSTATIN ANALOGS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. UNITED KINGDOM SOMATOSTATIN ANALOGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. SOMATOSTATIN ANALOGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 194. SOMATOSTATIN ANALOGS MARKET, FPNV POSITIONING MATRIX, 2023